RESUMEN
Acute ischemic stroke (AIS) is one of the most common strokes posing a grave threat to human life and health. Predicting the prognosis of AIS allows for an understanding of disease progress, and a better quality of life by making individualized treatment scheme. In this paper, we conducted a systematic search on PubMed, focusing on the relevant literature in the last 5 years. Summarizing the candidate prognostic biomarkers of AIS in body fluids such as blood, urine, saliva and cerebrospinal fluid is often of great significance for the management of acute ischemic stroke, which has the potential to facilitate early diagnosis, treatment, prevention and long-term outcome improvement.
Acute ischemic stroke stands as a prominent contributor to global mortality and disability rates. This comprehensive review delves into the present state and advancements in the study of prognostic biomarkers for AIS in body fluids, enabling the monitoring of disease progression and prediction of prognosis. Furthermore, we elucidate the utilization of multiple biomarkers to predict outcomes more precisely. This paper emphasizes the importance of predicting disease progression as early as possible so that clinicians can change treatment regimens in time to better treat their patients.
